Pfizer shot 100% effective in ages 12-15 - long-term study

Thursday, 23. December 2021 16:20

Pfizer Inc. and BioNTech SE announced on Thursday data from a longer-term follow-up of patients aged 12-15, which showed a two-dose series of its COVID-19 vaccine was 100% effective starting from seven days after vaccination through over four months. The phase 3 study included 2,228 individuals and recorded 30 cases of COVID-19 infection, all in the placebo group.

The companies stated the observed side-effects were "generally consistent with other clinical safety data for the vaccine." They added the data was submitted to the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA).

Related Links: BioNTech SEPfizer Inc.
Baha Breaking the News (BBN) / DJ